Azenta Plunges on Wider 1Q Loss, Earnings Miss

Dow Jones

02/04

By Elias Schisgall

Shares of Azenta plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter.

Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months.

Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier.

On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet.

Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 04, 2026 10:59 ET (15:59 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2609395065"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609395065\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609395065?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 23:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609395065","market":"hk","top_or_hot":-1,"title":"Azenta Plunges on Wider 1Q Loss, Earnings Miss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/AZTA\">Azenta</a> plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter. \n</p>\n<p>\n  Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months. \n</p>\n<p>\n  Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet. \n</p>\n<p>\n  Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 10:59 ET (15:59 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Azenta Plunges on Wider 1Q Loss, Earnings Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAzenta Plunges on Wider 1Q Loss, Earnings Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-04 23:59</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/AZTA\">Azenta</a> plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter. \n</p>\n<p>\n  Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months. \n</p>\n<p>\n  Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet. \n</p>\n<p>\n  Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 10:59 ET (15:59 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZTA","symbol_name":"Azenta","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2609395065","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609395065","pubTimestamp":1770220740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Azenta plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter.Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months.Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier.On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet.Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"AZTA":"Azenta"},"translate_title":"Azenta第一季度亏损扩大，盈利未达预期，股价暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZTA":1.5},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Azenta plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter. \n\n\n  Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months. \n\n\n  Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier. \n\n\n  On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet. \n\n\n  Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 10:59 ET (15:59 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}